Article

Effectiveness of the ChAdOx1 vaccine in the elderly during SARS-CoV-2 Gamma variant transmission in Brazil

2021-07-22

Abstract excerpt

<h4>Background</h4> A two-dose regimen of ChAdOx1 coronavirus disease 19 (Covid-19) vaccine with an inter-dose interval of three months has been implemented in many countries with restricted vaccine supply. However, there is limited evidence for the effectiveness of ChAdOx1 by dose in elderly populations in countries with high prevalence of the Gamma variant of severe acute respiratory syndrome 2 (SARS-CoV-2). <h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ed962c98-a7fb-5745-b7c8-58ff4a792a7e
DOI: 10.1101/2021.07.19.21260802

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of the ChAdOx1 vaccine in the elderly during SARS-CoV-2 Gamma variant transmission in BrazilDOI 10.1101/2021.07.19.21260802Read

Effectiveness of the CoronaVac vaccine in the elderly population during a Gamma variant-associated epidemic of COVID-19 in Brazil: A test-negative case-control studySemantic proximity Read

Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control studySemantic proximity Read

Influence of age on the effectiveness and duration of protection in Vaxzevria and CoronaVac vaccinesSemantic proximity Read

Vaccine Coverage and Effectiveness Against Laboratory-Confirmed Symptomatic and Severe COVID-19 in Indigenous People in Brazil: A Cohort StudySemantic proximity Read

Effectiveness of COVID-19 Vaccines Against Hospitalization in Latin America During Three Pandemic Waves, 2021-2022: A Test-Negative Case-Control DesignSemantic proximity Read

Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in FranceSemantic proximity Read

Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021Semantic proximity Read

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)Semantic proximity Read

Effectiveness of COVID-19 Vaccines Against SARS-CoV-2 Infection During a Delta Variant Epidemic Surge in Multnomah County, Oregon, July 2021Semantic proximity Read

Effectiveness of the Single-Dose Ad26.COV2.S COVID VaccineSemantic proximity Read

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil; an exploratory analysis of a randomised controlled trialSemantic proximity Read

Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian citySemantic proximity Read